Guidance

Batch testing medicines if there's no Brexit deal

How batch testing medicines would be affected if the UK leaves the EU with no deal.

From:
Department of Health and Social Care
Published
23 August 2018
Last updated
14 September 2018 — See all updates

This publication was withdrawn on

This guidance has been superseded by ‘Businesses supplying medicines and medical devices – what to expect on day one of a ‘no deal’ scenario’.

Documents

Batch testing medicines if there’s no Brexit deal

HTML

Details

If the UK leaves the EU without a deal, we’ll continue to:

  • accept batch testing of human medicines carried out in countries on a list from the Medicines and Healthcare products Regulatory Agency (MHRA)
  • require a UK, EU or EEA-based qualified person (QP) to certify batch testing
Published 23 August 2018
Last updated 14 September 2018 + show all updates

  1. Updated to inform that the notices may sometimes apply to businesses and citizens in the EEA.

  2. First published.

Related content